GlassScriptPhysician profile
Gary F Bloemer
NPI 1104884550
$1,329.72
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $465 · 2021: $277.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $517.23 | 2019-2021 | |
| Bioventus LLC | $292.45 | 2019-2020 | |
| Horizon Therapeutics Plc | $123.12 | 2020 | |
| Pacira Therapeutics, INC. | $120.57 | 2019 | |
| Stryker Corporation | $91.80 | 2019 | |
| Depuy Synthes Sales INC. | $60.47 | 2019-2020 | |
| Alpha Orthopedic Systems | $33.55 | 2019-2021 | |
| Smith+Nephew, INC. | $31.25 | 2019 | |
| Avanos Medical | $25.39 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.21 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.68 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bloemer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.